• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
5 Things to Know About Delta-8 Tetrahydrocannabinol: Delta-8 THC.关于δ-8四氢大麻酚（Delta-8 THC）需要了解的五件事
Mo Med. 2022 Jan-Feb;119(1):21-22.
2
Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.人体口服大麻素后血浆中的Δ⁹-四氢大麻酚、11-羟基-Δ⁹-四氢大麻酚和11-去甲-9-羧基-Δ⁹-四氢大麻酚
Ther Drug Monit. 2006 Aug;28(4):545-51. doi: 10.1097/00007691-200608000-00010.
3
Development of tolerance and cross-tolerance to the cataleptogenic effects of delta 8-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice.小鼠对δ8-四氢大麻酚和11-羟基-δ8-四氢大麻酚致僵效应的耐受性及交叉耐受性的发展
Eur J Pharmacol. 1983 Oct 28;94(3-4):349-51. doi: 10.1016/0014-2999(83)90427-2.
4
Investigation of phase II metabolism of 11-hydroxy-Δ-9-tetrahydrocannabinol and metabolite verification by chemical synthesis of 11-hydroxy-Δ-9-tetrahydrocannabinol-glucuronide.研究 11-羟基-Δ9-四氢大麻酚的 II 期代谢物，并通过化学合成 11-羟基-Δ9-四氢大麻酚-葡糖苷酸验证代谢产物。
Int J Legal Med. 2020 Nov;134(6):2105-2119. doi: 10.1007/s00414-020-02387-w. Epub 2020 Aug 17.
5
Discriminative stimulus effects of delta 9-tetrahydrocannabinol and delta 9-11-tetrahydrocannabinol in rats and rhesus monkeys.δ9-四氢大麻酚和δ9-11-四氢大麻酚对大鼠和恒河猴的辨别性刺激作用。
Neuropharmacology. 1993 Apr;32(4):359-65. doi: 10.1016/0028-3908(93)90157-x.
6
Cross-tolerance to the hypothermic effect of delta 8-tetrahydrocannabinol 11-hydroxy-delta 8-tetrahydrocannabinol and chlorpromazine in the mouse.小鼠对δ8-四氢大麻酚、11-羟基-δ8-四氢大麻酚和氯丙嗪低温效应的交叉耐受性。
Eur J Pharmacol. 1985 May 8;111(2):159-66. doi: 10.1016/0014-2999(85)90752-6.
7
Δ9-tetrahydrocannabinol and its major metabolite Δ9-tetrahydrocannabinol-11-oic acid as 15-lipoxygenase inhibitors.Δ9-四氢大麻醇及其主要代谢物 Δ9-四氢大麻醇-11-羧酸作为 15-脂氧合酶抑制剂。
J Pharm Sci. 2011 Mar;100(3):1206-11. doi: 10.1002/jps.22354. Epub 2010 Oct 1.
8
Emergence of the less common cannabinoid Δ -Tetrahydrocannabinol in a doping sample.在一份兴奋剂检测样本中出现了较罕见的大麻素Δ-四氢大麻酚。
Drug Test Anal. 2021 Nov;13(11-12):1936-1943. doi: 10.1002/dta.3159. Epub 2021 Sep 15.
9
Dronabinol Prescribing and Exposure Among Children and Young Adults Diagnosed with Cancer.大麻隆（屈大麻酚）处方与儿童和青年癌症患者的暴露情况。
J Adolesc Young Adult Oncol. 2021 Apr;10(2):175-184. doi: 10.1089/jayao.2020.0021. Epub 2020 Jul 14.
10
Schedules of Controlled Substances: Placement of FDA-Approved Products of Oral Solutions Containing Dronabinol [(-)-delta-9-trans- tetrahydrocannabinol (delta-9-THC)] in Schedule II. Final rule.《管制物质清单》：将含屈大麻酚[(-)-δ-9-反式-四氢大麻酚(δ-9-THC)]的口服溶液FDA批准产品列入附表II。最终规则。
Fed Regist. 2017 Nov 22;82(224):55504-6.

引用本文的文献

1
Associations between cannabis risk perceptions and Delta-8 THC use among young adults.大麻风险认知与年轻成年人中δ-8四氢大麻酚使用之间的关联。
J Subst Use. 2025;30(2):223-229. doi: 10.1080/14659891.2023.2293798. Epub 2023 Dec 14.
2
Differences in Online Descriptions and Marketing of Derived Intoxicating Cannabis Products.衍生致瘾性大麻产品的在线描述与营销差异。
J Psychoactive Drugs. 2025 Mar 25:1-11. doi: 10.1080/02791072.2025.2484376.
3
Considerations for Research in States with Recent or Pending Legalization of Non-Medical Cannabis: Lessons Learned from Alcohol and Opportunities for Research.近期非医用大麻合法化或即将合法化的州的研究考量：从酒精研究中吸取的经验教训及研究机会
Curr Addict Rep. 2024 Aug;11(4):666-671. doi: 10.1007/s40429-024-00579-7. Epub 2024 May 6.
4
Psychiatric Manifestations of Delta-8-Tetrahydrocannabinol (Δ8-THC) Use Among Patients With Preexisting Psychiatric Disorders: A Case Series.已有精神疾病患者使用δ-8-四氢大麻酚（Δ8-THC）的精神症状：病例系列
Cureus. 2025 Feb 25;17(2):e79621. doi: 10.7759/cureus.79621. eCollection 2025 Feb.
5
5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2025.5. 促进积极的健康行为和福祉以改善健康结局：2025年糖尿病照护标准
Diabetes Care. 2025 Jan 1;48(Supplement_1):S86-S127. doi: 10.2337/dc25-S005.
6
Derived cannabinoid product availability among online vape shops.在线电子烟商店中衍生大麻素产品的可获得性。
Prev Med Rep. 2024 Oct 22;48:102910. doi: 10.1016/j.pmedr.2024.102910. eCollection 2024 Dec.
7
Derived psychoactive cannabis product perceptions and use among a sample of US young adults.从美国年轻成年人样本中得出的致幻型大麻素产品认知和使用情况。
Addict Behav. 2025 Jan;160:108180. doi: 10.1016/j.addbeh.2024.108180. Epub 2024 Sep 26.
8
"Non-Flavor" Flavors: What Are the Implications of Derived Psychoactive Cannabis Product Marketing?“无风味”风味：衍生的精神活性大麻产品营销有何影响？
J Stud Alcohol Drugs. 2024 Sep;85(5):756-758. doi: 10.15288/jsad.24-00174. Epub 2024 Jul 12.
9
Select Minor Cannabinoids from Are Cannabimimetic and Antinociceptive in a Mouse Model of Chronic Neuropathic Pain.选择来源于大麻的低浓度大麻素具有大麻样作用并能缓解慢性神经病理性疼痛的小鼠模型中的疼痛。
J Pharmacol Exp Ther. 2024 Oct 18;391(2):214-221. doi: 10.1124/jpet.124.002212.
10
Driving Under the Influence of Alcohol, Cannabis, and Delta-8 THC: Perceived Likelihood, Risk Perceptions, and Behaviors.在酒精、大麻和δ-8四氢大麻酚影响下驾驶：感知可能性、风险认知与行为
J Psychoactive Drugs. 2024 Apr 9:1-10. doi: 10.1080/02791072.2024.2339506.

5 Things to Know About Delta-8 Tetrahydrocannabinol: Delta-8 THC.

出版信息

Mo Med. 2022 Jan-Feb;119(1):21-22.

PMID:36033151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9312454/
Abstract
摘要